on November 26, 2009
Prestigious Lecture Award for Federica Sallusto of the IRB
Leading immunologist Professor Federica Sallusto has been asked to give the 2009 Novartis Behring Lecture on the 25th of November at the University of Marburg. Since 2000 Sallusto leads a group of researchers at the Insititute for Research in Biomedicine in Belinzona. She holds a professorship in immunology at the University of Palermo, Italy and is the first woman to have been awarded the honor of giving the Novartis Behring Lecture.
Professor Federica Sallusto will join the ranks of leading scientists and nobel laureates who have received the Novartis Behring Lecture Award and was selected by the jury because of her outstanding and innovative research. Her area of focus is T-cell immunology and the interaction of T cells with dendritic cells.
Her recent work has provided valuable insight into the mecchanisms leading to automimmune disseases of the brain, including Multiple Scelrosis. “As there there currentily is neither prevention nor cure for this disease, the results achieved by Prof. Sallusto are very encouraging.” Said Dr. Mark Leyck Dieken, CEO of Novartis Vaccines.
Sponsored by Chiron Behring and Philipps-University Marburg, the Behring Lecture awards outstanding scientists from the fields of immunology, virology or microbiology. The prize was founded in October 1985 by the Board of the former Behringwerke AG to mark the 100th anniversary of the Hygiene Institute of the Philipps-University.
Prestigious Lecture Award for Federica Sallusto of the IRB
Leading immunologist Professor Federica Sallusto has been asked to give the 2009 Novartis Behring Lecture on the 25th of November at the University of Marburg. Since 2000 Sallusto leads a group of researchers at the Insititute for Research in Biomedicine in Belinzona. She holds a professorship in immunology at the University of Palermo, Italy and is the first woman to have been awarded the honor of giving the Novartis Behring Lecture.
Professor Federica Sallusto will join the ranks of leading scientists and nobel laureates who have received the Novartis Behring Lecture Award and was selected by the jury because of her outstanding and innovative research. Her area of focus is T-cell immunology and the interaction of T cells with dendritic cells.
Her recent work has provided valuable insight into the mecchanisms leading to automimmune disseases of the brain, including Multiple Scelrosis. “As there there currentily is neither prevention nor cure for this disease, the results achieved by Prof. Sallusto are very encouraging.” Said Dr. Mark Leyck Dieken, CEO of Novartis Vaccines.
Sponsored by Chiron Behring and Philipps-University Marburg, the Behring Lecture awards outstanding scientists from the fields of immunology, virology or microbiology. The prize was founded in October 1985 by the Board of the former Behringwerke AG to mark the 100th anniversary of the Hygiene Institute of the Philipps-University.
| Novartis Behring Lecturers | |
| Prof. Dr. Federica Sallusto, Bellinzona | 2009 |
| Prof. Dr. Ralf Bartenschlager, Heidelberg | 2008 |
| Prof. Dr. Sebastian Suerbaum, Hannover | 2007 |
| Prof. Dr. Hans-Hartmut Peter, Freiburg | 2006 |
| Prof. Dr. Franz Xaver Heinz, Wien | 2005 |
| Prof. Dr. Ernst Th. Rietschel, Borstel | 1999 |
| Prof. Dr. Ernst-Ludwig Winnacker, München | 1995 |
| Prof. Dr. Peter H. Krammer, Heidelberg | 1994 |
| Prof. Dr. Dr. h. c. mult. Harald zur Hausen, Heidelberg (Nobel Prize for Medicine 2008) | 1993 |
| Prof. Dr. Holger W. Jannasch, Woods Hole | 1992 |
| Prof. Dr. Charles Weissmann, Zürich | 1991 |
| Prof. Dr. Anthony Cerami, New York | 1990 |
| Prof. Dr. Günter Blobel, New York (Nobel Prize for Medicine 1999) | 1989 |
| Prof. Julius Adler, University of Wisconsin, USA | 1988 |
| Prof. Dr. Luc Montagnier, Paris (Nobel Prize for Medicine 2008) | 1986 |
| Prof. Dr. Gerald M. Edelman, New York (Nobel Prize for Medicine 1972) | 1985 |
